WuXi Biologics

WuXi Biologics WuXi Biologics is a leading global open-access biologics technology platform offering end-to-end sol

02/26/2025

Fewer risks, fewer delays: unlock the potential of microbial biologics!

Join Dr. Sam Zhang for this on-demand webinar and explore how WuXi Biologics’ advanced microbial capabilities can accelerate your journey from DNA to BLA and beyond.
✔ Seamless scalability—Effortlessly move from strain development to commercial production.
✔ Innovative solutions—Optimize production of enzymes, recombinant proteins, and other microbial biologics.
✔ Real-world applications—Gain insights from from exclusive case studies and expert commentary.

A must-watch for: outsourcing, supply, and project managers; CMC leaders; and scientists.
Watch now 👉https://www.wuxibiologics.com/novel-biologics-development-manufacturing-with-wuxi-biologics-microbial-platform/

Will you be attending the 19th International Symposium on Recent Advances in Drug Delivery Systems (February 25-28) in S...
02/12/2025

Will you be attending the 19th International Symposium on Recent Advances in Drug Delivery Systems (February 25-28) in Salt Lake City, Utah? Our team will be available to discuss partering needs for your cutting-edge technologies and latest breakthroughs in drug delivery. Contact us and we'll set up a convenient time to discuss the potential for partnering with us.

You may also request a meeting here: https://www.wuxibiologics.com/request-meeting/

Will you be in New York City for DCAT Week (March 17-20)? If so, let's connect at the Lotte New York Palace to discuss ...
02/05/2025

Will you be in New York City for DCAT Week (March 17-20)? If so, let's connect at the Lotte New York Palace to discuss your 2025 R&D and drug manufacturing goals. Contact us and we’ll set up a convenient time to learn about your outsourcing or partnering needs.

You may also request a meeting here: https://www.wuxibiologics.com/request-meeting/

🚀 WuXi Biologics New Publication Alert! 🚀We are excited to share our latest paper, "Rapid Development of High-Concentrat...
01/29/2025

🚀 WuXi Biologics New Publication Alert! 🚀

We are excited to share our latest paper, "Rapid Development of High-Concentration Protein Formulation Driven by High-Throughput Technologies." This research explores how high-throughput technologies are revolutionizing protein formulation, enabling faster, more efficient development of high-concentration biotherapeutics. By leveraging automation and data-driven approaches, we can significantly accelerate formulation timelines while ensuring stability and efficacy.

If you're working in biopharmaceuticals, protein engineering, or formulation science, this paper offers valuable insights into cutting-edge methodologies that can enrich your R&D pipeline and accelerate development timelines.

📖 Read the full paper here: [https://rdcu.be/d6F8o]

Kudos to all the authors and thank you to reviewers from Research, the official journal of American Associate of Pharmaceutical Scientists.

We want to hear your thoughts—let’s discuss! 👇
https://www.wuxibiologics.com/contact-us/

10/31/2024

Produce more product in less time and with fewer resources. 🙌 Innovations at WuXi Biologics have transformed continuous downstream processing, unlocking a powerful combination of higher productivity, lower costs, and enhanced process control. We achieved 16.1 g/L resin/hour with high monomer purity and low host cell protein levels, significantly improving resin productivity.

🚀Our on-demand webinar with Dr. Yifeng Li and Cell Culture Dish covers all the details, including how you can apply these insights to optimize your own continuous downstream processing process efficiency.

Access the recording here https://www.wuxibiologics.com/continuous-downstream-processing-webinar/

Will you be attending BIO-Europe (November 4-6) in Stockholm, Sweden? Our team will be available at booth #156 to dis...
10/24/2024

Will you be attending BIO-Europe (November 4-6) in Stockholm, Sweden? Our team will be available at booth #156 to discuss your R&D and drug manufacturing goals. Contact us and we'll set up a convenient time to discuss your outsourcing or partnering needs. Request a meeting: https://www.wuxibiologics.com/request-meeting/

Will you be attending the SITC Annual Meeting (November 6-10) in Houston, TX? Our team will be available at booth #120...
10/03/2024

Will you be attending the SITC Annual Meeting (November 6-10) in Houston, TX? Our team will be available at booth #1209 to discuss your R&D and drug manufacturing goals. Contact us and we'll set up a convenient time to discuss your outsourcing or partnering needs. Request a meeting: https://www.wuxibiologics.com/request-meeting/

10/03/2024

On-demand Webinar: Avoid the costly pitfalls of antibody development. The early stages of antibody engineering often focus on binding, specificity, cross-reactivity, and so on at the expense of developability and manufacturability. This on-demand webinar explores the importance of incorporating developability assessments early in the drug discovery process to streamline optimization and ensure successful therapeutic development.

Watch the webinar on demand: https://www.wuxibiologics.com/drug-discovery-developability-webinar/?utm_source=linkedin&utm_medium=teaser&utm_campaign=linkedin_teaser_2024&utm_content=webinar_developability

Register today for "Innovative Production and Engineering Strategies for Fab, ScFv & VHH." https://attendee.gotowebinar....
04/05/2024

Register today for "Innovative Production and Engineering Strategies for Fab, ScFv & VHH." https://attendee.gotowebinar.com/register/426332773275820636?source=SocialMedia

Antibody fragments like Fab, ScFv, and VHH are emerging stars in antibody drug development, utilized both as standalone molecules and as building blocks of bispecific antibodies. However, their production and engineering face numerous challenges, including issues related to yield, purity, throughput, and stability. In this webinar, we will unveil innovative strategies to overcome these challenges, tailored to the distinctive characteristics of Fab, ScFv, and VHH. We’ll provide key insights into molecular design, high-titer CHO transient and stable production and effective purification methods to accelerate your development of antibody fragments.

During the webinar, you will gain valuable insight into:
• Novel strategies to tackle common production challenges like low yields, throughput issues, and impurities in antibody fragment production.
• Advanced molecule engineering and linker design to mitigate aggregation and increase yield.
• Tailored approaches for optimizing the production of Fab, ScFv, and VHH, with a focus on specific strategies for each fragment type.

Will you be attending PEGS Boston (May 13-17)? If so, our representative team would like to connect at booth #700 and d...
04/03/2024

Will you be attending PEGS Boston (May 13-17)? If so, our representative team would like to connect at booth #700 and discuss your 2024 R&D goals. Contact us and we’ll set up a convenient time to learn about your outsourcing or partnering needs. Request a meeting: https://www.wuxibiologics.com/request-meeting/

Address

Cranbury, NJ

Website

Alerts

Be the first to know and let us send you an email when WuXi Biologics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to WuXi Biologics:

Shortcuts

Share